Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy

ClinicalTrials.gov ID: NCT05442021

Public ClinicalTrials.gov record NCT05442021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Impact of Direct Current Neuromuscular Electrical Stimulation on Physical Therapy Treatment of Peripheral Neuropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.

Study identification

NCT ID
NCT05442021
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
148 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2022
Primary completion
May 19, 2023
Completion
May 19, 2023
Last update posted
May 24, 2023

2022 – 2023

United States locations

U.S. sites
11
U.S. states
6
U.S. cities
11
Facility City State ZIP Site status
APEX Physical Therapy Cape Coral Florida 33991
Catalyst Physical Therapy Clearwater Florida 33756
APEX Physical Therapy Fort Myers Florida 33908
Diagnostic Solutions Springfield Kentucky 40069
Hands-On Physical Therapy Astoria New York 11106
Hands-On Physical Therapy of Queens Village Queens Village New York 11428
Panetta Physical Therapy & Diagnostics Ronkonkoma New York 11779
Courcier Physical Therapy Edmond Oklahoma 73013
Spine & Rehab Specialists El Paso Texas 79936
Active Fitness Physical Therapy Oak Hill West Virginia 25901
Active Fitness Physical Therapy Victor West Virginia 25938

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05442021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05442021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →